10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway

10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway

Glucose homeostasis relies on dynamic balancing between storage (glycogenesis), mobilization (glycogenolysis), de novo synthesis (gluconeogenesis), and alternative shunt pathways (pentose phosphate pathway). Mastery of these metabolic pathways and their clinical genetic disorders is essential for NPLEX Part I candidates.

---

Glycogen Metabolism & Reciprocal Regulation

Glycogen is a branched polymer of glucose stored predominantly in the liver (maintains systemic blood glucose during fasting) and skeletal muscle (provides immediate fuel for muscle contraction).

• Linkages: Linear chains consist of $\alpha$-1,4 glycosidic bonds; branches occur every 8–12 residues via $\alpha$-1,6 glycosidic bonds.

Glycogenesis (Glycogen Synthesis)

• Pathway: Glucose $\rightarrow$ G6P $\rightarrow$ G1P $\rightarrow$ UDP-Glucose (catalyzed by UDP-glucose pyrophosphorylase).
• Rate-Limiting Enzyme: Glycogen Synthase, which adds UDP-glucose to the non-reducing ends of glycogen chains via $\alpha$-1,4 bonds.
• Branching Enzyme: Amylo-($1,4 \rightarrow 1,6$)-transglucosidase creates $\alpha$-1,6 branch points.
• Hormonal Regulation: Activated by Insulin (fed state). Insulin stimulates protein phosphatase-1 (PP-1), which dephosphorylates Glycogen Synthase, converting it to its active (a) form. Activated allosterically by Glucose-6-Phosphate.

Glycogenolysis (Glycogen Breakdown)

• Rate-Limiting Enzyme: Glycogen Phosphorylase, which cleaves $\alpha$-1,4 linkages via phosphorolysis, releasing Glucose-1-Phosphate (G1P) until 4 glucose residues remain before a branch point (a limit dextrin).
• Debranching Enzyme: A bifunctional protein possessing:
  1. 4-$\alpha$-D-glucanotransferase: Transfers 3 terminal glucose residues from the branch to an adjacent linear chain.
  2. $\alpha$-1,6-glucosidase: Hydrolytically cleaves the single remaining $\alpha$-1,6 linked glucose residue, releasing free glucose.
• Hormonal / Allosteric Regulation: Activated by Glucagon (liver) and Epinephrine (liver and muscle) via cAMP / Protein Kinase A (PKA) cascade. PKA phosphorylates Glycogen Phosphorylase Kinase, which phosphorylates Glycogen Phosphorylase into its active (a) form.
  • Muscle-Specific Allosteric Activation: Activated by AMP and $\text{Ca}^{2+}$ (via calmodulin subunit), signaling active muscle contraction without requiring hormonal input.

---

Glycogen Storage Diseases (GSDs)

Inherited enzyme deficiencies in glycogen synthesis or breakdown result in distinctive organomegaly, hypoglycemia, or muscle weakness.

---

Gluconeogenesis: De Novo Glucose Synthesis

Occurring primarily in the liver (and to a lesser extent in the kidney cortex during prolonged starvation), gluconeogenesis synthesizes glucose from non-carbohydrate precursors: Lactate, Glycerol (from adipose triglyceride breakdown), and Glucogenic Amino Acids (predominantly Alanine and Glutamine).

Bypassing the 3 Irreversible Glycolytic Steps

To drive flux in the anabolic direction, gluconeogenesis uses 4 unique enzymes to bypass the 3 thermodynamically irreversible steps of glycolysis:

Glycolysis Step 10: PEP ──────────► Pyruvate
  Gluconeogenesis Bypass 1:
    1a. Pyruvate (Mitochondria) + CO2 + ATP ──[Pyruvate Carboxylase (B7)]──► Oxaloacetate
    1b. Oxaloacetate + GTP ──[PEP Carboxykinase (PEPCK)]──► Phosphoenolpyruvate (PEP)

Glycolysis Step 3: Fructose-6-P ──► Fructose-1,6-BP
  Gluconeogenesis Bypass 2 (RATE-LIMITING STEP):
    Fructose-1,6-BP + H2O ──[Fructose-1,6-Bisphosphatase]──► Fructose-6-P + Pi

Glycolysis Step 1: Glucose ───────► Glucose-6-P
  Gluconeogenesis Bypass 3:
    Glucose-6-P + H2O ──[Glucose-6-Phosphatase (ER Membrane)]──► Free Glucose + Pi

• Fructose-1,6-Bisphosphatase (FBPase-1): The primary rate-limiting enzyme of gluconeogenesis.
  • Inhibited by: Fructose-2,6-bisphosphate (F2,6BP) and AMP.
  • Activated by: Citrate and ATP (signaling energy surplus).
• Glucose-6-Phosphatase: Embedded in the endoplasmic reticulum membrane of liver and kidney cells; absent in skeletal muscle (explaining why muscle glycogen cannot directly contribute to systemic blood glucose).

---

Pentose Phosphate Pathway (HMP Shunt)

Occurring entirely in the cytoplasm, the Pentose Phosphate Pathway (Hexose Monophosphate Shunt) branches from Glucose-6-Phosphate. It produces NADPH and Ribose-5-phosphate without consuming or generating ATP.

Two Phases of the HMP Shunt

1. Irreversible Oxidative Phase:
   • Rate-Limiting Enzyme: Glucose-6-Phosphate Dehydrogenase (G6PD).
   • Converts Glucose-6-P $\rightarrow$ Ribulose-5-P, producing 2 NADPH and 1 $\text{CO}_2$.
   • Induced by Insulin; inhibited by high $\text{NADPH}/\text{NADP}^+$ ratio.
2. Reversible Non-Oxidative Phase:
   • Catalyzed by Transketolase (requires Vitamin B1 Thiamine) and Transaldolase.
   • Interconverts pentose phosphates with glycolytic intermediates (Glyceraldehyde-3-P and Fructose-6-P).

Cellular Functions of NADPH

• Reductive Biosynthesis: Fatty acid, cholesterol, and steroid hormone synthesis.
• Antioxidant Defense: Maintenance of reduced Glutathione ($\text{GSH}$) via Glutathione Reductase, protecting cell membranes against reactive oxygen species ($\text{H}_2\text{O}_2$).
• Phagocytic Respiratory Burst: Substrate for $\text{NADPH}$ Oxidase in neutrophils producing superoxide radicals for bacterial killing.

G6PD Deficiency

• Genetics: X-linked recessive disorder; most common enzymatic disorder worldwide.
• Pathophysiology: Decreased G6PD activity $\rightarrow$ insufficient NADPH production in erythrocyte cytosol $\rightarrow$ inability to regenerate reduced glutathione ($\text{GSH}$) $\rightarrow$ accumulation of reactive oxygen species during oxidative stress $\rightarrow$ oxidation of hemoglobin sulfhydryl groups.
• Histological & Microscopic Features:
  • Heinz Bodies: Denatured, precipitated hemoglobin aggregates visible on crystal violet stain.
  • Bite Cells (Degmacytes): Splenic macrophages pluck out Heinz bodies as RBCs pass through cords of Billroth.
• Triggers of Acute Hemolytic Episodes:
  1. Fava beans (favism).
  2. Infections (most common trigger; neutrophils release free radicals).
  3. Oxidative Drugs: Antimalarials (Primaquine), Sulfa drugs (Sulfamethoxazole), Nitrofurantoin, Rasburicase.